MedTrace Logo

Outcomes of Swallowing Rehabilitation After Stroke

NCT00288834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-02-08

No results posted yet for this study

Summary

This project proposes to evaluate the relative effectiveness of four therapy protocols for pharyngeal phase swallowing impairment in the stroke population. Data derived from this study should contribute significantly to our understanding of the rehabilitative process in the neurogenic dysphagic population and will provide the foundation for the establishment of efficacious, cost-efficient patient services.

1\. Research Question to be addressed

1. The utilization of SEMG biofeedback monitoring in dysphagia rehabilitation facilitates more rapid and complete recovery than traditional rehabilitation using the same swallowing exercises without exteroceptive feedback.
2. Swallowing rehabilitation provided in an intensive rehabilitative programme (10 hrs of treatment in the 1st week) facilitates more rapid and complete recovery than traditionally scheduled swallowing rehabilitation (twice weekly).

Conditions

Interventions

BEHAVIORAL

dysphagia rehabilitation

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER

  • Tan Tock Seng Hospital

    collaborator OTHER

  • Fremantle Hospital and Health Service

    collaborator OTHER

  • Austin Hospital, Melbourne Australia

    collaborator OTHER

  • University of Canterbury

    lead OTHER

Principal Investigators

  • Maggie-Lee Huckabee, Ph.D. · University of Canterbury, Van der Veer Institute for Parkinson's and Brain Research, Christchurch New Zealand

  • Catriona M. Steele, Ph.D. · Toronto Rehabilitation Institute, Toronto Canada

  • Pascal van Lieshout, Ph.D. · University of Toronto, Toronto Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-08-31
Completion
2006-07-31

Countries

  • Australia
  • Canada
  • New Zealand
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00288834 on ClinicalTrials.gov